Le Lézard
Classified in: Health
Subjects: NEW PRODUCTS/SERVICES, PARTNERSHIPS, MISCELLANEOUS, MISCELLANEOUS

Millennium BlockChain Announces Major Investment in Online Broker Dealer ChoiceTrade


Millennium BlockChain, first publicly traded company to conduct stock swaps for equity in blockchain companies, partners with ChoiceTrade to introduce the next generation of trading

LAS VEGAS / SAN JUAN, PUERTO RICO, March 26, 2018 (GLOBE NEWSWIRE) -- Millennium BlockChain, Inc. (OTC:MBLC), a holding company focused on blockchain technologies and crypto-assets today announced it had signed a letter of intent to purchase 24 percent of ChoiceTrade Holdings, Inc. ("ChoiceTrade") in the securities brokerage firm's shares, "ChoiceTrade Shares."

Millennium Blockchain intends to exchange 4.5 million shares of its common stock and an equal number of warrants at a strike price of $3 for its 24 percent stake in ChoiceTrade.

"Millennium BlockChain's partnership with ChoiceTrade will provide more financial value for stock investors and crypto investors alike," said Brandon Romanek, CEO of Millennium BlockChain and seasoned trader. "It's a privilege to partner with ChoiceTrade and leverage their technology and regulatory expertise as they become a significant player in the fast-evolving blockchain space."

During the six months following the close of the transaction, Millennium BlockChain intends to fund ChoiceTrade in the amount of $10 million or more to spur ChoiceTrade's growth.

"We are extremely excited to have Millennium BlockChain as our second largest shareholder and adding a crypto asset class to our company's offerings," said Neville Golvala, CEO and founder of ChoiceTrade. "Millennium BlockChain's executive team brings a robust network and experience in the blockchain industry and crypto asset class to ChoiceTrade's offerings, which benefits both companies as we work together to bring favorable circumstances to holders' assets as well as increase our customer base."

ChoiceTrade plans to introduce an arrangement with one or more cryptocurrency exchanges for its trading platform, and following the completion of its technology upgrade, its customers will have the ability to trade crypto on its platform.

"Bitcoin and other cryptocurrencies have recently become popular with investors, yet there weren't any fully integrated online brokers that offered the ability to trade them, and customers had to go directly to specialized crypto exchanges," said Enzo Villani, Chairman of Millennium BlockChain. "The ability to integrate cryptocurrency trading with ChoiceTrade's additional trading platform offerings will be a significant competitive advantage distinguishing ChoiceTrade from other trading platforms, and we anticipate that execution of our plans will increase professional institutional investor interest in both parties."

About Millennium BlockChain
Millennium BlockChain, Inc. (OTC:MBLC) is a holding company primarily focused on blockchain technologies and crypto-assets in financial markets, healthcare, crypto-mining and high technology sectors. For more information, visit www.mblockchain.io.

About ChoiceTrade
ChoiceTrade Holdings, Inc. is the parent company of ChoiceTrade, an advanced-technology securities brokerage firm founded in New Jersey in 2000 and headquartered in San Juan, Puerto Rico since 2015. We cater to active, self-directed traders and are committed to making available the most state-of-the-art tools that give our customers their best opportunities for realizing success in their trading strategies. Each trading platform that we offer is geared toward a specific trading style. On April 1, 2018, ChoiceTrade will launch a zero commission model for customers transacting listed equities and exchange-traded funds (ETF).

Our management team includes individuals with extensive experience in the securities industry. Being at the forefront, and playing leading roles in the technological and regulatory initiatives that shape the industry, provide the insight necessary to fulfill the firm's 'one-step-ahead' approach to the products it offers. For more information, visit www.choicetrade.com.

Media Contact:
Transform Group, [email protected]

Forward-Looking Statements Disclosure:
This press release may contain "forward-looking statements" within the meaning of the federal securities laws. In this context, forward-looking statements may address the Company's expected future business and financial performance, and often contain words such as "anticipates," "beliefs," "estimates," "expects," "intends," " plans," "seeks," "will," and other terms with similar meaning. These forward-looking statements by their nature address matters that are, to different degrees, uncertain. Although the Company believes that the assumptions upon which its forward-looking statements based are reasonable, it can provide no assurances that these assumptions will prove to be correct. All forward-looking statements in this press release are expressly qualified by such cautionary statements, risk, and uncertainties, and by reference to the underlying assumptions.

 



These press releases may also interest you

at 10:10
The group division of Ameritas proudly announces its 17th consecutive certification as a BenchmarkPortal Center of Excellence, solidifying its position as a leader in customer service and support excellence. This prestigious recognition for 2023...

at 10:05
The "Distribution Deals in Diagnostics 2016 to 2024" report has been added to ResearchAndMarkets.com's offering. Distribution Deals in Diagnostics provides a detailed understanding and analysis of how and why companies enter distribution deals....

at 10:00
Driving is the leading cause of work-related death each year in the United States, with nearly 40% of deaths on the job occurring on American roads according to the U.S. Bureau of Labor Statistics. A major contributing factor to road deaths each...

at 10:00
Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced the recent launch of Methimazole Tablets, USP, 5 mg and 10 mg. The Methimazole Tablet market had U.S. sales of approximately $36.8 million for the 12 months ending December 2023 according...

at 10:00
NastLaw LLC announces: If you purchased certain named generic pharmaceutical drugs directly from certain pharmaceutical manufacturers from May 1, 2009 through December 31, 2019, your rights may be affected by proposed class action settlements.A...

at 09:48
Perspire Sauna Studio, one of the country's largest sauna franchises specializing in full spectrum infrared (IR) and red-light therapy (RLT), is rolling out a new sauna design and member experience through the brand's long-standing partnership with...



News published on and distributed by: